Ireland· IE-PA-PA22650/002/002
Centyl K 2.5 mg/573 mg modified-release tablets
A bendroflumethiazide and potassium product containing bendroflumethiazide + potassium chloride, registered in Ireland by Karo Pharma AB. The same ATC class is registered in 5 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Bendroflumethiazide and potassium is registered in 5 of 19 countries.
Countries holding a registration under ATC C03AB01 (bendroflumethiazide and potassium), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 2 of them publish a price we can compare per daily dose
Bendroflumethiazide and potassium · ATC C03AB01
5 / 19 countries
- Denmark
- Icelandprice
- Ireland
- Norwayprice
- United Kingdom
The record
At a glance
HPRA (Ireland)- Active substance
- Bendroflumethiazide + Potassium chloride
- Manufacturer
- Karo Pharma AB
- Country
- Ireland (IE)
- ATC code
- C03AB01
- ATC class
- Bendroflumethiazide and potassium
- Defined daily dose
- 2.5 mg, O
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA22650/002/002
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Bendroflumethiazide and potassium in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NorwayBendrozaTeva B.V.
- United KingdomCentyl K modified-release tabletsLEO Pharma
- IcelandCentyl með kaliumkloridKaro Pharma AB*
- SwedenCentyl K 2,5 mg/573 mg Filmdragerad tablettKaro Pharma AB
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- Denmark · Bendroza, Centyl Med Kaliumklorid
- Iceland · Centyl Med Kaliumklorid, Centyl Mite Med Kaliumklorid
- Norway · Centyl Med Kaliumklorid, Centyl Mite Med Kaliumklorid
- Sweden · Centyl K, Centyl K Mite
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/0e46f513-3a29-4781-b74c-14c40454432f GET /v1/drugs/0e46f513-3a29-4781-b74c-14c40454432f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Modified-release tablet",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"C03AB",
"C03AB01"
],
"strength": null,
"pa_number": "PA22650/002/002",
"substances": [
"Bendroflumethiazide",
"Potassium chloride"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Marketed",
"authorised_at": "01/04/1978",
"dispensing_status": "Product subject to prescription which may be renewed (B)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about bendroflumethiazide and potassium.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.